Identifying Decision Making Needs for Older Adult Women With Stage I-III Breast Cancer Considering Neoadjuvant or Adjuvant Chemotherapy
NCT05049746 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 95
Last updated 2026-05-01
Summary
This study collects information and identifies decision making needs for older adult women with stage I-III breast cancer considering neoadjuvant and adjuvant chemotherapy. Using this information, a decision support tool is then developed to provide patients and physicians with tailored information regarding the risks and benefits of chemotherapy and values clarification to support high-quality, shared decision. Subsequently, the decision support tool will be tested amongst older patients with early-stage breast cancer and health care providers navigating the decision process around chemotherapy, and further refined through an iterative process.
Conditions
- Anatomic Stage I Breast Cancer AJCC v8
- Anatomic Stage IA Breast Cancer AJCC v8
- Anatomic Stage IB Breast Cancer AJCC v8
- Anatomic Stage II Breast Cancer AJCC v8
- Anatomic Stage IIA Breast Cancer AJCC v8
- Anatomic Stage IIB Breast Cancer AJCC v8
- Anatomic Stage III Breast Cancer AJCC v8
- Anatomic Stage IIIA Breast Cancer AJCC v8
- Anatomic Stage IIIB Breast Cancer AJCC v8
- Anatomic Stage IIIC Breast Cancer AJCC v8
- Prognostic Stage I Breast Cancer AJCC v8
- Prognostic Stage IA Breast Cancer AJCC v8
- Prognostic Stage IB Breast Cancer AJCC v8
- Prognostic Stage II Breast Cancer AJCC v8
- Prognostic Stage IIA Breast Cancer AJCC v8
- Prognostic Stage IIB Breast Cancer AJCC v8
- Prognostic Stage III Breast Cancer AJCC v8
- Prognostic Stage IIIA Breast Cancer AJCC v8
- Prognostic Stage IIIB Breast Cancer AJCC v8
- Prognostic Stage IIIC Breast Cancer AJCC v8
Interventions
- OTHER
-
Discussion
Participate in discussion
- OTHER
-
Interview
Participate in interview
- OTHER
-
Questionnaire Administration
Complete questionnaire
Sponsors & Collaborators
-
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Meghan Karuturi · M.D. Anderson Cancer Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 65 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-02-23
- Primary Completion
- 2027-02-02
- Completion
- 2027-02-02
Countries
- United States
Study Locations
More Related Trials
-
Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer
NCT00002460 ·Status: UNKNOWN ·Phase: PHASE3
-
Views and Attitudes of Oncologists and Geriatricians on the Use of Chemotherapy and Hormone Therapy in Treating Older and/or Frail Women With Breast Cancer
NCT00478283 ·Status: COMPLETED ·Phase: NA
-
Exercise During Chemotherapy in Older Women With Stage I-III Breast Cancer
NCT05025059 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Geriatric Care Survivorship Intervention for Improving the Overall Health of Older Adults With Stage I-III Breast Cancer Who Have Completed Curative Treatment
NCT05928325 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
An Innovative Smartphone Application for Adverse Event Management During Breast Cancer Adjuvant Chemotherapy
NCT05258461 ·Status: UNKNOWN ·Phase: NA
-
Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer
NCT01293032 ·Status: COMPLETED ·Phase: NA
-
Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients
NCT02995772 ·Status: COMPLETED ·Phase: PHASE3
-
Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer
NCT00002646 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective Observational Study About Adjuvant or Neoadjuvant Chemotherapy Related Adverse Effects in Premenopausal Breast Cancer Patients
NCT03543059 ·Status: UNKNOWN
-
Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast Cancer
NCT02769104 ·Status: UNKNOWN ·Phase: PHASE3
-
Clinical Study of Adjuvant Therapy on Post-menopausal Women With Breast Cancer Under the Guidance of the Results of Preoperative Endocrinotherapy
NCT01613560 ·Status: UNKNOWN ·Phase: PHASE2
-
Therapeutic Dose Monitoring (TDM) of Tamoxifen
NCT05133674 ·Status: UNKNOWN ·Phase: PHASE2
-
SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer
NCT00929591 ·Status: COMPLETED ·Phase: PHASE3
-
Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score
NCT02476786 ·Status: RECRUITING ·Phase: PHASE2
-
Quality of Life Analysis of Arimidex Treatment in Postmenopausal Patients With Breast Cancer
NCT00692289 ·Status: COMPLETED
-
Tamoxifen in Treating Women With Breast Cancer
NCT00003678 ·Status: UNKNOWN ·Phase: PHASE3
-
Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy
NCT05472792 ·Status: RECRUITING ·Phase: PHASE2
-
A Prospective Observational Study About Adjuvant or Neoadjuvant Chemotherapy Related Adverse Effects in Postmenopausal Breast Cancer Patients
NCT03543072 ·Status: UNKNOWN
-
Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer
NCT00002529 ·Status: COMPLETED ·Phase: PHASE3
-
Digital Patient Support Program for Self-efficacy and Medication Adherence in Women on Adjuvant Endocrine Treatment for Breast Cancer
NCT06989450 ·Status: RECRUITING ·Phase: NA
-
Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative Patients
NCT00309569 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients
NCT00309478 ·Status: COMPLETED ·Phase: PHASE3
-
PACED-digitized Support During Adjuvant Endocrine Therapy
NCT05084625 ·Status: RECRUITING ·Phase: NA
-
A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast Cancer
NCT04086875 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.
NCT00287534 ·Status: COMPLETED ·Phase: PHASE2